Contact tracing and genetic testing reveal how SARS-CoV-2 circulated among individuals for weeks, especially in the US, before being detected.

From artificial intelligence to pluripotent stem cells, this year saw the publication of a bevy of intriguing new methods, as well as tweaks to existing protocols.

Chips used by some direct-to-consumer genetic testing firms display a false positive rate of upwards of 85 percent when screening for rare variants, a new study finds.  

Researchers combine CRISPR technology with a graphene transistor to create an electronic sensor for particular DNA sequences.

A CRISPR-based electronic sensor flags target DNA sequences at high speed.

Its screen for selected variants of some disease-linked genes gives customers an incomplete picture of their risk—do they know?

The extremely rare event, thought to be caused by two sperm cells fertilizing the same egg simultaneously, was last reported in 2007.

Learning about your own genetic idiosyncrasies comes with complex emotions.

Data don’t support many direct-to-consumer products, from telomere assessments to bespoke diets based on genetic sequences.